Natera, Inc. (NTRA)
$326.27-$12.43 (-3.67%) Today
Jonathan Sheena - DirectorJonathan Sheena - DirectorJonathan Sheena - DirectorJonathan Sheena - DirectorJonathan Sheena - DirectorJonathan Sheena - DirectorNatera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 148 | 367,715 | $86.69M |
| Grant or award | 16 | 34,107 | |
| Option exercise | 2 | 22,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
244 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gail Boxer Marcus | Grant or award | Common Stock | 108 | - | - | |
| Gail Boxer Marcus | Grant or award | Common Stock | 222 | - | - | |
| Rowan E. Chapman | Grant or award | Common Stock | 114 | - | - | |
| Rowan E. Chapman | Grant or award | Common Stock | 222 | - | - | |
| Roelof Botha | Grant or award | Common Stock | 132 | - | - | |
| Roelof Botha | Grant or award | Common Stock | 222 | - | - | |
| Eric H. Rubin | Grant or award | Common Stock | 5 | - | - | |
| Brinkley Ruth Williams | Grant or award | Common Stock | 86 | - | - | |
| Monica Bertagnolli | Grant or award | Common Stock | 83 | - | - | |
| Roy D. Baynes | Grant or award | Common Stock | 83 | - | - | |
| Jonathan Sheena | Open-market sale | Common Stock | 750 | $199.66 | $150K | |
| Jonathan Sheena | Open-market sale | Common Stock | 750 | $199.59 | $150K | |
| Matthew Rabinowitz - Officer | Option exercise | Common Stock | 58,292 | $9.59 | $559K | |
| Matthew Rabinowitz - Officer | Tax withholding / forfeiture | Common Stock | 27,610 | $204.87 | $5.66M | |
| Matthew Rabinowitz - Officer | Option exercise | Stock Option (right to buy) | 58,292 | $0.00 | - | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 300 | $200.79 | $60K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 1,778 | $202.01 | $359K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 3,213 | $203.07 | $652K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 1,200 | $203.83 | $245K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 1,909 | $205.00 | $391K | |
 Solomon Moshkevich - Officer | Open-market sale | Common Stock | 1,048 | $201.32 | $211K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 1,000 | $202.36 | $202K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 952 | $203.31 | $194K | |
| Matthew Rabinowitz - Officer | Option exercise | Common Stock | 41,708 | $9.59 | $400K | |
| Matthew Rabinowitz - Officer | Option exercise | Stock Option (right to buy) | 41,708 | $0.00 | - | |
| Jonathan Sheena | Open-market sale | Common Stock | 300 | $196.27 | $59K | |
| Jonathan Sheena | Open-market sale | Common Stock | 956 | $197.84 | $189K | |
| Jonathan Sheena | Open-market sale | Common Stock | 1,814 | $198.65 | $360K | |
| Jonathan Sheena | Open-market sale | Common Stock | 239 | $198.85 | $48K | |
| Jonathan Sheena | Open-market sale | Common Stock | 140 | $199.82 | $28K | |
| Jonathan Sheena | Open-market sale | Common Stock | 371 | $200.97 | $75K | |
| Jonathan Sheena | Open-market sale | Common Stock | 235 | $198.49 | $47K | |
| Jonathan Sheena | Open-market sale | Common Stock | 235 | $199.88 | $47K | |
| Jonathan Sheena | Open-market sale | Common Stock | 280 | $200.90 | $56K | |
| Rowan E. Chapman | Open-market sale | Common Stock | 122 | $191.38 | $23K | |
| Matthew Rabinowitz - Officer | Option exercise | Common Stock | 75,000 | $9.59 | $719K | |
| Matthew Rabinowitz - Officer | Option exercise | Common Stock | 75,000 | $9.59 | $719K | |
| Matthew Rabinowitz - Officer | Option exercise | Common Stock | 50,000 | $9.59 | $480K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 8,091 | $186.75 | $1.51M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 5,809 | $187.52 | $1.09M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 6,451 | $188.52 | $1.22M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 2,886 | $189.64 | $547K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 22,063 | $190.53 | $4.20M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 9,896 | $191.55 | $1.90M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 8,579 | $192.79 | $1.65M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 7,043 | $193.58 | $1.36M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 4,082 | $194.57 | $794K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 100 | $195.32 | $20K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 17,037 | $187.63 | $3.20M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 21,476 | $188.54 | $4.05M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 21,504 | $189.50 | $4.08M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 13,883 | $190.46 | $2.64M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 1,100 | $191.22 | $210K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 100 | $190.07 | $19K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 300 | $190.68 | $57K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 900 | $192.43 | $173K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 2,300 | $194.17 | $447K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 4,875 | $195.42 | $953K | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 24,814 | $196.23 | $4.87M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 16,457 | $197.22 | $3.25M | |
| Matthew Rabinowitz - Officer | Open-market sale | Common Stock | 254 | $198.02 | $50K | |
| Matthew Rabinowitz - Officer | Option exercise | Stock Option (right to buy) | 75,000 | $0.00 | - | |
| Matthew Rabinowitz - Officer | Option exercise | Stock Option (right to buy) | 75,000 | $0.00 | - | |
| Matthew Rabinowitz - Officer | Option exercise | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Michael Burkes Brophy - Officer | Open-market sale | Common Stock | 785 | $204.13 | $160K | |
| Michael Burkes Brophy - Officer | Grant or award | Common Stock | 1,968 | - | - | |
| Steven Leonard Chapman - Officer | Grant or award | Common Stock | 5,623 | - | - | |
| Steven Leonard Chapman - Officer | Open-market sale | Common Stock | 5,623 | $204.13 | $1.15M | |
| Daniel Rabinowitz - Officer | Grant or award | Common Stock | 1,745 | - | - | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 1,745 | $204.13 | $356K | |
| Jonathan Sheena | Grant or award | Common Stock | 258 | - | - | |
| Jonathan Sheena | Open-market sale | Common Stock | 127 | $204.13 | $26K | |
| John Fesko - Officer | Open-market sale | Common Stock | 707 | $204.13 | $144K | |
| John Fesko - Officer | Grant or award | Common Stock | 1,774 | - | - | |
| Solomon Moshkevich - Officer | Grant or award | Common Stock | 1,774 | - | - | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 915 | $204.13 | $187K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 1,600 | $195.80 | $313K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 1,500 | $196.94 | $295K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 1,998 | $198.04 | $396K | |
| Daniel Rabinowitz - Officer | Option exercise | Stock Option (Right to Buy) | 5,598 | $0.00 | - | |
| Daniel Rabinowitz - Officer | Option exercise | Common Stock | 5,598 | $19.68 | $110K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 400 | $193.73 | $77K | |
| Daniel Rabinowitz - Officer | Open-market sale | Common Stock | 2,900 | $194.77 | $565K | |
| Jonathan Sheena | Grant or award | Common Stock | 2,103 | - | - | |
| Jonathan Sheena | Open-market sale | Common Stock | 470 | $198.50 | $93K | |
| Jonathan Sheena | Open-market sale | Common Stock | 2,400 | $200.42 | $481K | |
| Jonathan Sheena | Open-market sale | Common Stock | 100 | $201.20 | $20K | |
| Jonathan Sheena | Open-market sale | Common Stock | 100 | $202.85 | $20K | |
| Steven Leonard Chapman - Officer | Open-market sale | Common Stock | 365 | $201.18 | $73K | |
| Steven Leonard Chapman - Officer | Grant or award | Common Stock | 37,401 | - | - | |
| Steven Leonard Chapman - Officer | Open-market sale | Common Stock | 1,122 | $199.17 | $223K | |
| Steven Leonard Chapman - Officer | Open-market sale | Common Stock | 2,463 | $200.24 | $493K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 931 | $198.83 | $185K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 1,594 | $200.11 | $319K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 475 | $200.97 | $95K | |
| Solomon Moshkevich - Officer | Option exercise | Common Stock | 5,125 | $9.59 | $49K | |
| Solomon Moshkevich - Officer | Grant or award | Common Stock | 10,051 | - | - | |
| Solomon Moshkevich - Officer | Option exercise | Stock Option (right to buy) | 5,125 | $0.00 | - | |
| Matthew Rabinowitz - Officer | Grant or award | Common Stock | 29,920 | - | - | |
| Daniel Rabinowitz - Officer | Grant or award | Common Stock | 12,272 | - | - | |
| John Fesko - Officer | Grant or award | Common Stock | 10,051 | - | - | |
| Michael Burkes Brophy - Officer | Grant or award | Common Stock | 10,051 | - | - | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 80 | $228.50 | $18K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 878 | $229.96 | $202K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 576 | $230.84 | $133K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 850 | $232.33 | $197K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 600 | $233.24 | $140K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 16 | $234.00 | $4K | |
| Solomon Moshkevich - Officer | Open-market sale | Common Stock | 1,639 | $230.77 | $378K |
This is as far as the anonymous view goes. Create a free account for all 244 NTRA filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Sheena Jonathan | Director | 18,000 | $5.95M | View on EDGAR | |
| TINKERBELLE II TR U/A DTD 10/22/2021 | Officer, Director | 2,000 | $642K | View on EDGAR | |
| MICHAEL BROPHY | Officer | 478 | $129K | View on EDGAR |
Natera, Inc. (NTRA) had 43 insider filings in the last 90 days, with the most recent on 2026-08-29. The full record for NTRA runs to 244 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NTRA were filed in the last 90 days.
148 insider sales of NTRA were filed in the last 90 days, totaling $86.69M.
This page tracks NTRA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NTRA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
